| Metabolic reprogramming and its clinical application in thyroid cancer | |
| Wu, Wei-Li; Shi, Rong-Liang; Qu, Ning; Zhu, Yong-Xue; Ji, Qing-Hai; Wang, Yu; Wang, Yu-Long; Wen, Shi-Shuai; Zhang, Ting-Ting; Xue, Di-Xin | |
| 刊名 | ONCOLOGY LETTERS
 |
| 2019 | |
| 卷号 | 18期号:2 |
| 关键词 | thyroid cancer metabolism prognosis predictive factor targeted therapy |
| ISSN号 | 1792-1074 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3594554 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wu, Wei-Li,Shi, Rong-Liang,Qu, Ning,et al. Metabolic reprogramming and its clinical application in thyroid cancer[J]. ONCOLOGY LETTERS,2019,18(2). |
| APA | Wu, Wei-Li.,Shi, Rong-Liang.,Qu, Ning.,Zhu, Yong-Xue.,Ji, Qing-Hai.,...&Xue, Di-Xin.(2019).Metabolic reprogramming and its clinical application in thyroid cancer.ONCOLOGY LETTERS,18(2). |
| MLA | Wu, Wei-Li,et al."Metabolic reprogramming and its clinical application in thyroid cancer".ONCOLOGY LETTERS 18.2(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论